Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice
Lab / animal
OA: bronze
CC0
⤵ 12 in-corpus citations
AI-generated summary
This study investigated the impact of the angiogenesis inhibitor TNP-470 on the progression of uterine adenomyosis in a mouse model, detailing observed effects.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To investigate the effects of angiogenesis inhibitor TNP-470 on uterine microvessels in mice. Pituitary grafting frequently induced uterine adenomyosis.
DESIGN: In vivo experimental study.
SETTING: Department of Biological Sciences, University of Tokyo and Medical Research Institute, Tokyo Medical and Dental University.
ANIMAL(S): SHN mice, which are known to develop uterine adenomyosis spontaneously, and also very soon after pituitary grafting.
INTERVENTION(S): Immunohistochemical study on uterine blood vessels using an antibody to von Willebrand factor in pituitary gland-implanted mice with or without TNP-470.
MAIN OUTCOME MEASURE(S): Reduced incidence of uterine adenomyosis.
RESULT(S): Twelve of 15 mice developed uterine adenomyosis with dilated blood vessels, but none of the TNP-470-treated mice with shrunken microvessels. The number of bromodeoxyuridine immunoreactive cells and activities of thymidylate synthase and thymidine kinase in uterine tissues were markedly reduced in TNP-470-treated mice.
CONCLUSION(S): TNP-470, a potent inhibitor of the development of vascular endothelium, reduced the development of endometrial blood vessels resulting in a lowered incidence of uterine adenomyosis induced by pituitary grafting in mice, and reduced the increase in S-phase cells and enzyme activity for pyrimidine nucleotide synthesis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (33)
- Changes in Uterine Microvessels as a Possible Pathogenic Factor in the Development of Adenomyosis Induced by Pituitary Grafting in Mice. via openalex
- Disturbed Cell Arrangement, Increased Cell Membrane Permeability and Apoptotic Cell Death Occur in Adenomyotic Uterine Tissues in Mice via openalex
- Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas via openalex
- Effects of mifepristone (RU486) treatment on the development of uterine adenomyosis induced by pituitary grafting in mice via openalex
- Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure via openalex
- Mechanisms of development of prolactin-induced adenomyosis in mice via openalex
- Morphometric evaluation of stromal vascularization in the endometrium in adenomyosis via openalex
- Prolactin and Uterine Adenomyose in Mice via openalex
- The induction of adenomyosis in mice by intrauterine pituitary isografts via openalex
- W2011197306 via openalex
- W2019850232 via openalex
- W2041769554 via openalex
- W2048930729 via openalex
- W2064204050 via openalex
- W2086157929 via openalex
- W2088254867 via openalex
- W2112942470 via openalex
- W2150816401 via openalex
- W2161295454 via openalex
- W2167541685 via openalex
- W2261190893 via openalex
- W6634417623 via openalex
- W6635517444 via openalex
- W1517900928 via openalex
- W6693079684 via openalex
- W1574165892 via openalex
- W1590774636 via openalex
- W1950574246 via openalex
- W1967781859 via openalex
- W1972273438 via openalex
- W1978139448 via openalex
- W1990138449 via openalex
- W2010435021 via openalex
Cited by (13)
- Correlations between TSC Expression and Menorrhagia in Adenomyosis Patients 2026
- Immunometabolic profiling of cervicovaginal lavages identifies key signatures associated with adenomyosis 2022
- Increased Angiogenesis and Lymphangiogenesis in Adenomyosis Visualized by Multiplex Immunohistochemistry 2022
- Animal Models of Adenomyosis 2020
- Benign Uterine Diseases 2019
- Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review 2019
- Improving the Preclinical Mouse Efficacy Studies of Adenomyosis 2015
- Constitutive and tumor necrosis factor-α-induced activation of nuclear factor-κB in adenomyosis and its inhibition by andrographolide 2013
- Literature Review on Biological Effects of against Gynaecological Diseases 2013
- Methodological Issues in Preclinical Mouse Efficacy Studies of Adenomyosis 2012
- Increased immunoreactivity to SLIT/ROBO1 and its correlation with severity of dysmenorrhea in adenomyosis 2010
- Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1alpha (HIF-1alpha), and microvessel density in endometrial tissue in women with adenomyosis 2009
- Evaluation of the efficacy of a danazol-loaded intrauterine contraceptive device on adenomyosis in an ICR mouse model 2008
Source provenance
- europepmc
- last seen: 2026-10-16T06:09:50.462052+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:02:06.159351+00:00
License: CC0
· commercial use OK